Artelo Biosciences announces 1-for-9 reverse stock split effective Aug 28, 2026

ARTELO BIOSCIENCES, INC.

Reverse split ratio 1-for-9, effective 5:00 p.m. ET Aug 28, 2026; split-adjusted trading begins Aug 31, 2026.
Outstanding shares reduced from 4,929,966 to ~547,774; authorized shares cut from 500M to 55,555,556.
New CUSIP 04301G805; no fractional shares, each fractional share rounds up to one whole share.
Warrants and derivatives adjust per terms; shareholder pro-rata ownership unchanged.
Purpose: improve marketability and liquidity of common stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.